Clinical trial

GSK706769 Repeat Dose Study

NCT00711386

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-05-16

PhasePHASE1

Study timeline

Study start (actual)2008-05-16Date precision: day

Registry last updated2017-08-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Infection, Human Immunodeficiency Virusunresolved

Interventions

GSK706769DRUG

PlaceboOTHER

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

MadisonWisconsin, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00711386 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.